Combination therapy for Burkitt's lymphoma dramatically improves cure rates in mice
Burkitt’s lymphoma is a rare and aggressive blood cancer characterized by translocation of the MYC gene. It occurs most often in children and young adults. In recent years, CAR-T cell therapy – often referred to as a “survival drug” and administered as a single dose – has been approved for some types of blood cancers,…
